Innovative lead discovery strategies for tropical diseases (Q36642049)

15 August 2017

1 reference

title

Innovative lead discovery strategies for tropical diseases (English)

1 reference

15 August 2017

1 reference

Solomon Nwaka

1

1 reference

PubMed ID

17080030

15 August 2017

Alan Hudson

series ordinal

2

1 reference

15 August 2017

1 November 2006

1 reference

Nature Reviews Drug Discovery

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

941-955

1 reference

15 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd2144

15 August 2017

0 references

cites work

Drug development for neglected diseases: a deficient market and a public-health policy failure

1 reference

Virtual drug discovery and development for neglected diseases through public-private partnerships

21 January 2018

1 reference

Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines

21 January 2018

1 reference

Opportunities and Challenges in Antiparasitic Drug Discovery

21 January 2018

1 reference

Hit and lead generation: beyond high-throughput screening

21 January 2018

1 reference

Identification of an antimalarial synthetic trioxolane drug development candidate

21 January 2018

1 reference

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

21 January 2018

1 reference

RNAi-based discovery and validation of new drug targets in filarial nematodes

21 January 2018

1 reference

Antimalarial drug discovery: old and new approaches

21 January 2018

1 reference

Current strategies in the search for novel antiparasitic agents

21 January 2018

1 reference

Strategic emphases for tropical diseases research: a TDR perspective.

21 January 2018

1 reference

Research on infectious diseases requires better coordination

21 January 2018

1 reference

The life and times of ivermectin - a success story

21 January 2018

1 reference

The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans

21 January 2018

1 reference

Antimalarial drug discovery: efficacy models for compound screening

21 January 2018

1 reference

Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

21 January 2018

1 reference

Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents.

21 January 2018

1 reference

Genome sequence of the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

Comparative genomics of trypanosomatid parasitic protozoa

21 January 2018

1 reference

Chemistry-to-gene screens in Caenorhabditis elegans

21 January 2018

1 reference

Integration of virtual and high-throughput screening

21 January 2018

1 reference

Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei

21 January 2018

1 reference

A clinical drug library screen identifies astemizole as an antimalarial agent

21 January 2018

1 reference

Navigating chemical space for biology and medicine

21 January 2018

1 reference

Global mapping of pharmacological space

21 January 2018

1 reference

Computational methods for the prediction of 'drug-likeness'

21 January 2018

1 reference

Insights into antifolate resistance from malarial DHFR-TS structures

21 January 2018

1 reference

Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data

21 January 2018

1 reference

High-throughput crystallography for lead discovery in drug design.

21 January 2018

1 reference

The process of structure-based drug design

21 January 2018

1 reference

Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'.

21 January 2018

1 reference

Taking inventory: antibacterial agents currently at or beyond phase 1.

21 January 2018

1 reference

Antibiotics: where did we go wrong?

21 January 2018

1 reference

High-throughput drug discovery: what can we expect from HTS?

21 January 2018

1 reference

A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi.

21 January 2018

1 reference

Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue

21 January 2018

1 reference

Designing drugs for parasitic diseases of the developing world

21 January 2018

1 reference

Academia-industry partnerships in drug discovery.

21 January 2018

1 reference

Health Innovation Networks to Help Developing Countries Address Neglected Diseases

21 January 2018

1 reference

Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis

21 January 2018

1 reference

21 January 2018

1 reference

The price of innovation: new estimates of drug development costs

21 January 2018

1 reference

TDR collaboration with the pharmaceutical industry

21 January 2018

1 reference

High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase

21 January 2018

1 reference

Parasitology. Drugs to combat tropical protozoan parasites

21 January 2018

1 reference

PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data

21 January 2018

1 reference

Finding cures for tropical diseases: is open source an answer?

21 January 2018

1 reference

Comparative genomics of nematodes

21 January 2018

1 reference

The impact of whole genome sequence data on drug discovery--a malaria case study

31 March 2020

1 reference

Public health. Gates Foundation picks winners in Grand Challenges in Global Health

31 March 2020

1 reference

Invited Perspective: Screening in Academe: A Perspective on Implementation of University-Based Small Molecule Screening

31 March 2020

1 reference

High-throughput screening in academia: the Harvard experience

31 March 2020

1 reference

A breakthrough in R&D; for neglected diseases: new ways to get the drugs we need

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD2144

1 reference

15 August 2017

1 reference

PubMed ID

17080030